Your browser doesn't support javascript.
loading
Renoprotective effects of the novel prostaglandin EP4 receptor-selective antagonist ASP7657 in 5/6 nephrectomized chronic kidney disease rats.
Mizukami, Kazuhiko; Yoshida, Hiroyuki; Nozawa, Eisuke; Wada, Koichi; Ugawa, Tohru.
Affiliation
  • Mizukami K; Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba, Ibaraki, 305-8585, Japan. kazuhiko.mizukami@astellas.com.
  • Yoshida H; Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba, Ibaraki, 305-8585, Japan.
  • Nozawa E; Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba, Ibaraki, 305-8585, Japan.
  • Wada K; Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba, Ibaraki, 305-8585, Japan.
  • Ugawa T; Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba, Ibaraki, 305-8585, Japan.
Naunyn Schmiedebergs Arch Pharmacol ; 392(4): 451-459, 2019 04.
Article in En | MEDLINE | ID: mdl-30554341
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinolines / Mesylates / Protective Agents / Renal Insufficiency, Chronic / Receptors, Prostaglandin E, EP4 Subtype / Indoles Limits: Animals Language: En Journal: Naunyn Schmiedebergs Arch Pharmacol Year: 2019 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinolines / Mesylates / Protective Agents / Renal Insufficiency, Chronic / Receptors, Prostaglandin E, EP4 Subtype / Indoles Limits: Animals Language: En Journal: Naunyn Schmiedebergs Arch Pharmacol Year: 2019 Document type: Article Affiliation country: Country of publication: